Factors associated with self-rated sexual function in Korean patients with schizophrenia receiving risperidone monotherapy

Human Psychopharmacology

Volumn 30, Issue 6, 2015, Pages 416-424

  Lee, Ju Yeon ^a   Kim, Sung Wan ^a   Lee, Yo Han ^b   Kang, Hee Ju ^a   Kim, Seon Young ^a   Bae, Kyung Yeol ^a   Kim, Jae Min ^a   Shin, Il Seon ^a   Yoon, Jin Sang ^a  

^a Chonnam National University Medical School   (South Korea)

^b St John Hospital   (South Korea)

Author keywords

adherence; risperidone; schizophrenia; sexual arousal; sexual function; well being

Indexed keywords

RISPERIDONE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DEMOGRAPHY; DISEASE DURATION; DRUG ATTITUDE INVENTORY; FEMALE; HUMAN; INVESTIGATIVE PROCEDURES; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MARRIAGE; MONOTHERAPY; NEUROLOGIC DISEASE ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL DESIRE; SEXUAL FUNCTION; SEXUAL SATISFACTION; SUBJECTIVE WELL BEING UNDER NEUROLEPTIC TREATMENT BRIEF FORM SCALE; TARDIVE DYSKINESIA; VISUAL ANALOG SCALE; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; SEX DIFFERENCE; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SOUTH KOREA; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REPUBLIC OF KOREA; RISPERIDONE; SCHIZOPHRENIA; SEX FACTORS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84947035062     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2489     Document Type: Article

References (68)

1. Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A,. 1995. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 56: 137-141.
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders DSM-IV, 4th edn. American Psychiatric Publishing: Washington, DC.
3. Andia AM, Zisook S, Heaton RK, et al., 1995. Gender differences in schizophrenia. J Nerv Ment Dis 183: 522-528.
4. Baggaley M,. 2008. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol 23: 201-209.
5. Baldwin DS, Foong T,. 2013. Antidepressant drugs and sexual dysfunction. Br J Psychiatry 202: 396-397.
6. Barnes TR,. 1989. A rating scale for drug induced akathisia. Br J Psychiatry 154: 672-676.
7. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J,. 1961. An inventory of measuring depression. Arch Gen Psychiatry 4: 53-63.
8. Bobes J, Garc APMP, Rejas J, et al., 2003. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 29: 125-147.
9. Casper RC, Redmond DE, Jr, Katz MM, Schaffer CB, Davis JM, Koslow SH,. 1985. Somatic symptoms in primary affective disorder: presence and relationship to the classification of depression. Arch Gen Psychiatry 42: 1098-1104.
10. Cutler AJ,. 2003. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 28 (Suppl 1): 69-82.
11. Dossenbach M, Dyachkova Y, Pirildar S, et al., 2006. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 21: 251-258.
12. Eaton WW,. 1975. Marital status and schizophrenia. Acta Psychiatr Scand 52: 320-329.
13. Fan X, Henderson DC, Chiang E, et al., 2007. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res 94: 119-127.
14. Fenton WS, Wyatt RJ, McGlashan TH,. 1994. Risk factors for spontaneous dyskinesia in schizophrenia. Arch Gen Psychiatry 51: 643-650.
15. Finn SE, Bailey JM, Schultz RT, Faber R,. 1990. Subjective utility ratings of neuroleptics in treating schizophrenia. Psychol Med 20: 843-848.
16. Fujii A, Yasui-Furukori N, Sugawara N, et al., 2010. Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 34: 288-293.
17. Ghadirian AM, Chouinard G, Annable L,. 1982. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 170: 463-467.
18. Guy W,. 1976. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare: Washington, DC; 534-537.
19. Hahn HM, Yum TH, Shin YW, et al., 1986. Standardization study of Beck Depression Inventory in Korea. J Korean Neuropsychiatr Assoc 25: 487-502.
20. Herings RM, Erkens JA,. 2003. Increased suicide attempt rate among patients interrupting use of atypical antipsychotics. Pharmacoepidemiol Drug Saf 12: 423-424.
21. Hogan TP, Awad AG, Eastwood R,. 1983. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13: 177-183.
22. Howes OD, Wheeler MJ, Pilowsky LS, Landau S, Murray RM, Smith S,. 2007. Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. J Clin Psychiatry 68: 361-367.
23. Hummer M, Huber J,. 2004. Hyperprolactinemia and antipsychotic therapy in schizophrenia. Curr Med Res Opin 20: 189-197.
24. Karow A, Czekalla J, Dittmann RW, et al., 2007. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. J Clin Psychiatry 68: 75-80.
25. Kay SR, Fiszbein A, Opler LA,. 1987. The Positive and Negative Syndrome Scale for schizophrenia. Schizophr Bull 13: 261-276.
26. Kelly DL, Conley RR,. 2006. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology 31: 340-346.
27. Kikuchi T, Iwamoto K, Sasada K, Aleksic B, Yoshida K, Ozaki N,. 2012. Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients taking antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 37: 26-32.
28. Kim SW, Yoon JS, Choi SK,. 2006. Survey of medication adherence in patients with schizophrenia-Korean ADHES data. Hum Psychopharmacol 21: 533-537.
29. Kim SW, Shin IS, Kim JM, et al., 2007a. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 31: 1504-1509.
30. Kim SW, Shin IS, Kim JM, et al., 2007b. A validation study of the Korean version of Subjective Well-being under Neuroleptic Treatment Scale-short form. Korean J Psychopharmacol 18: 221-230.
31. Kim SW, Shin IS, Kim JM, et al., 2009a. Effectiveness of switching to aripiprazole from antipsychotics in patients with schizophrenia. Clin Neuropharmacol 32: 243-249.
32. Kim SW, Shin IS, Kim JM, et al., 2009b. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia. Hum Psychopharmacol 24: 565-573.
33. Kim SW, Chung YC, Lee YH, et al., 2012a. Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial. Int Clin Psychopharmacol 27: 267-274.
34. Kim SW, Yoon JS, Kim YS, et al., 2012b. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 38: 228-235.
35. Kinon BJ, Gilmore JA, Liu H, Halbreich UM,. 2003. Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials. Psychoneuroendocrinology 28 (Suppl 2): 69-82.
36. Knegtering H, van der Moolen AE, Castelein S, Kluiter H, van den Bosch RJ,. 2003. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 28 (Suppl 2): 109-123.
37. Lambert M, Conus P, Eide P, et al., 2004. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry 19: 415-422.
38. Lambert M, Naber D,. 2004. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 18 (Suppl 2): 5-17.
39. Laumann EO, Nicolosi A, Glasser DB, et al., 2005. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 17: 39-57.
40. Lewis RW, Fugl-Meyer KS, Bosch R, et al., 2004. Epidemiology/risk factors of sexual dysfunction. J Sex Med 1: 35-39.
41. Lyketsos GC, Sakka P, Mailis A,. 1983. The sexual adjustment of chronic schizophrenics: a preliminary study. Br J Psychiatry 143: 376-382.
42. Macdonald S, Halliday J, MacEwan T, et al., 2003. Nithsdale Schizophrenia Surveys 24: sexual dysfunction: case-control study. Br J Psychiatry 182: 50-56.
43. Malik P, Kemmler G, Hummer M, et al., 2011. Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial. J Clin Psychopharmacol 31: 274-280.
44. Montejo AL, Majadas S, Rico-Villademoros F, et al., 2010. Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics. J Sex Med 7: 3404-3413.
45. Moreira ED, Jr, Hartmann U, Glasser DB, et al., 2005. A population survey of sexual activity, sexual dysfunction and associated help-seeking behavior in middle-aged and older adults in Germany. Eur J Med Res 10: 434-443.
46. Moreira ED, Jr, Kim SC, Glasser DB, et al., 2006. Sexual activity, prevalence of sexual problems, and associated help-seeking patterns in men and women aged 40-80 years in Korea: data from the Global Study of Sexual Attitudes and Behaviors (GSSAB). J Sex Med 3: 201-211.
47. Naber D, Moritz S, Lambert M, et al., 2001. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res 50: 79-88.
48. Nicolosi A, Glasser DB, Kim SC, et al., 2005. Sexual behavior and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries. BJU Int 95: 609-614.
49. Offman A, Matheson K,. 2005. Sexual compatibility and sexual functioning in intimate relationships. Can J Hum Sex 14: 31-39.
50. Paredes RG, Agmo A,. 2004. Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence. Prog Neurobiol 73: 179-226.
51. Perkins DO,. 2002. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 63: 1121-1128.
52. Perkins DO, Johnson JL, Hamer RM, et al., 2006. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res 83: 53-63.
53. Razali MS, Yahya H,. 1995. Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatr Scand 91: 331-335.
54. Salokangas RKR, Honkonen T, Stengård E, et al., 2001. To be or not to be married-that is the question of quality of life in men with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 36: 381-390.
55. Simpson GM, Angus JWS,. 1970. A rating scale for extrapyramidal side effect. Acta Psychiatr Scand 212 (suppl): 11-19.
56. Smith SM, O'Keane V, Murray R,. 2002. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181: 49-55.
57. Tan HM, Low WY, Ng CJ, et al., 2007. Prevalence and correlates of erectile dysfunction (ED) and treatment seeking for ED in Asian Men: the Asian Men's Attitudes to life Events and Sexuality (MALES) study. J Sex Med 4: 1582-1592.
58. Tenback DE, van Harten PN, Slooff CJ, et al., 2006. Tardive dyskinesia in schizophrenia is associated with prolactin-related sexual disturbances. Neuropsychopharmacology 31: 1832-1837.
59. Uçok A, Incesu C, Aker T, Erkoç S,. 2007. Sexual dysfunction in patients with schizophrenia on antipsychotic medication. Eur Psychiatry 22: 328-333.
60. Valenstein M, Copeland LA, Blow FC, et al., 2002. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 40: 630-639.
61. Verhulst J, Schneidman B,. 1981. Schizophrenia and sexual functioning. Hosp Community Psychiatry 32: 259-262.
62. Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W,. 2007. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31: 703-712.
63. Westheide J, Cvetanovska G, Albrecht C, et al., 2008. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone. J Sex Med 12: 2816-2826.
64. Yang J, Ko YH, Paik JW, et al., 2012. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia. Schizophr Res 134: 226-231.
65. Yi JS, Ahn YM, Shin HK, et al., 2001. Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. J Korean Neuropsychiatr Assoc 40: 1090-1105.
66. Yoon BH, Bahk WM, Lee KU, et al., 2005. Psychometric properties of Korean version of Drug Attitude Inventory (KDAI-10). Korean J Psychopharmacol 16: 480-487.
67. Zhang XR, Zhang ZJ, Zhu RX, Yuan YG, Jenkins TA, Reynolds GP,. 2011. Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes. Pharmacogenomics 12: 1127-1136.
68. Zisook S, Nyer M, Kasckow J, Golshan S, Lehman D, Montross L,. 2006. Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression. Schizophr Res 86: 226-233.